About Me

Name:Average Voter
Biography
Loading...

Create Your Own Blog Find Other Townhall Blogs

Comments

Archives

Blog Search

Climate Change Is Effecting Drug Maker GlaxoSmithKline

     Timesonline Business Editor James Harding writes that the unusual winter in Britain has hurt the Blackcurrant crop of which 95% is purchased by GlaxoSmithKline for use in their product Ribena. In his article, he never mentions what Ribena is, so when I read it, I figured it was some kind of important drug.

    But on further inspection; I just don't think that if the climate was to go haywire, that Ribena would be a huge loss. I doubt people will be dying in the streets because they didn't get their fruit flavored energy drink.

But that is not all. It seems that GlaxoSmithKline has been wading in some public controversy related to their vitamin drink product. Read about it here. They are very sorry as stated in this public apology on their website concerning all the misleading things about their product and their advertising.
    
    So, the premise of the TimesOnline article seems a little weak, don't you think? 
 

Email ItEmail It | Print ItPrint It | CommentsComments (0) | TrackbacksTrackbacks (0) | Flag as offensiveFlag as Offensive